And so I think it still remains the case that a multidisciplinary program thats evidence based will continue to deliver better and more sustained outcomes for patients with obesity and be an appropriate solution for patients with these types of conditions, just as having specialty care is appropriate for patients with cardiac conditions, pulmonary conditions, endocrine conditions
Emerging evidence suggests that women receiving hormone therapy demonstrate more favorable weight loss trajectories and body composition outcomes when treated with GLP-1 based therapies than those who are not, particularly in women with preserved metabolic flexibility [16,17]
Ch Thc phm ny khng phi l thuc v khng c tc dng thay th thuc cha bnh
Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM et al (2013) Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study
Background on the Gene Therapy Life Biosciences Will Test Life Biosciences gene therapy has been under development for quite a while
Kidney Int 89:862873